Find comprehensive information on Condyloma Acuminata (Anogenital Warts, Venereal Warts) diagnosis, including clinical documentation, ICD-10 codes, medical coding guidelines, and healthcare best practices. Learn about effective treatment options and relevant medical terminology for accurate and efficient patient care related to Condyloma Acuminata and its associated symptoms. This resource is valuable for healthcare professionals, medical coders, and clinicians seeking reliable information on Anogenital Warts and Venereal Warts.
Also known as
Anogenital (venereal) warts
Caused by human papillomavirus (HPV) infection.
Viral warts
Warts on the skin caused by a virus.
Infections with a predominantly sexual mode of transmission
Infections primarily spread through sexual contact.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the Condyloma Acuminata caused by HPV?
When to use each related code
| Description |
|---|
| Genital warts caused by HPV. |
| Flat, smooth genital lesions, often subclinical HPV. |
| Cervical cell changes caused by HPV, can lead to cancer. |
Missing or inaccurate coding of specific HPV subtypes associated with Condyloma Acuminata impacts treatment and surveillance.
Lack of precise documentation of the anatomical location (e.g., cervix, penis) can lead to coding errors and affect quality metrics.
Misdiagnosis or inadequate documentation to differentiate condyloma from other similar lesions (e.g., pearly penile papules) can lead to inaccurate coding.
Q: What are the most effective differential diagnosis strategies for Condyloma Acuminata vs. other similar-appearing lesions in the anogenital region?
A: Differentiating Condyloma Acuminata (anogenital warts) from other lesions like condyloma lata (secondary syphilis), pearly penile papules, vestibular papillomatosis, or squamous cell carcinoma requires a multi-faceted approach. Visual inspection, noting morphology and location, is crucial. Acetic acid application (vinegar test) can highlight the acetowhite change characteristic of Condyloma Acuminata, though it isn't entirely specific. Histopathological examination via biopsy provides definitive diagnosis, especially in atypical cases or when malignancy is suspected. Consider implementing HPV typing, especially if treatment isn't responsive, to identify the specific HPV strain involved. Explore how high-resolution anoscopy may assist in identifying subclinical lesions in patients with suspected or confirmed Condyloma Acuminata. For lesions suspicious for syphilis, serological testing is essential. Learn more about distinguishing features of common anogenital lesions to enhance diagnostic accuracy.
Q: What are the current best-practice treatment recommendations for Condyloma Acuminata, considering patient preferences and potential recurrence?
A: Treatment for Condyloma Acuminata focuses on lesion removal and symptom relief, but complete HPV eradication is often challenging. Patient preference plays a key role in choosing among the various treatment options, including topical agents (podofilox, imiquimod, sinecatechins), provider-administered treatments (cryotherapy, trichloroacetic acid, surgical excision, electrocautery), and laser therapy. Recurrence rates vary significantly depending on the treatment modality and HPV strain involved. Shared decision-making is crucial; discuss potential side effects, treatment duration, and the possibility of recurrence with the patient. Explore how combination therapies might improve outcomes in persistent cases. Consider implementing a follow-up schedule that includes regular examinations to monitor for recurrence and assess treatment efficacy. Learn more about optimizing treatment protocols for different clinical scenarios and patient populations.
Patient presents with complaints consistent with anogenital warts, clinically diagnosed as Condyloma Acuminata. Examination reveals characteristic flesh-colored to pink papillomatous lesions in the perianal region. Differential diagnosis includes molluscum contagiosum, seborrheic keratosis, and skin tags. HPV infection is the established etiology. Patient reports no significant past medical history of sexually transmitted infections. Sexual history was obtained, and risk factors for STIs were discussed. Patient education provided regarding HPV transmission, prevention, and the potential for recurrence. No systemic symptoms reported. Treatment plan includes topical application of imiquimod cream, with patient instructed on proper application and potential side effects. Follow-up appointment scheduled to monitor treatment response and assess for lesion resolution. ICD-10 code A63.0 (Anogenital (venereal) warts) assigned. Patient counseling included discussion of safe sex practices, partner notification, and HPV vaccination. Prognosis generally good with appropriate treatment and adherence to recommended follow-up care.